{"id":{"repo_id":"bradford","oai_identifier":"oai:bradscholars.brad.ac.uk:10454/20643"},"canonical_url":"https://search.dev.ndltd.org/etd/bradford/oai:bradscholars.brad.ac.uk:10454/20643","repository":{"repo_id":"bradford","name":"University of Bradford","base_url":"https://bradscholars.brad.ac.uk/oai/request"},"display":{"title":"Evaluation of new succinimide-based small molecules as alphavbeta3 integrin antagonists: from design to preliminary biological testing","abstract":"Integrins are a family of cell surface protein receptors consisting of two subunits, called α and β, involved in several biological processes, including regulation of signalling between cells and other cells or ECM. Integrins are overexpressed in diseases, first of all cancer. Being able to bind several ligands which contain the endogenous peptidic motif, RGD, αvβ3 is the most important of the family, associated with angiogenesis and aggressiveness of the tumour. However, molecules designed as antagonists based on RGD have shown partial agonism. This limit may be overpassed by switching from RGD to isoDGR motif. Here, some isoDGR analogues prodrugs have been designed and synthesised, by a multi-step route to obtain the different fragments (isoAsp, Gly and Arg) subsequently connected together [Fig. A.01]. The molecules have been tested in ex-vivo metabolism assay in liver, kidney and tumour tissues. Cytotoxicity has been tested for all compounds in M14 and DLD1 cell lines: no effect was observed in MTT assay. Migration inhibition has been evaluated by performing scratch assay on M14 and DLD1 cell lines. Compound 4 has shown the best migration inhibition, with IC50 = 4.62 ± 1.70 μM at 12h and IC50 = 5.63 ± 1.77 μM at 24h. [Fig A.01] The work made in this project can be used as preliminary evaluation for a deeper investigation in succinamides-based prodrugs as integrins antagonists.","abstract_html":"Integrins are a family of cell surface protein receptors consisting of two subunits, called α and β, involved in several biological processes, including regulation of signalling between cells and other cells or ECM. Integrins are overexpressed in diseases, first of all cancer. Being able to bind several ligands which contain the endogenous peptidic motif, RGD, αvβ3 is the most important of the family, associated with angiogenesis and aggressiveness of the tumour. However, molecules designed as antagonists based on RGD have shown partial agonism. This limit may be overpassed by switching from RGD to isoDGR motif. Here, some isoDGR analogues prodrugs have been designed and synthesised, by a multi-step route to obtain the different fragments (isoAsp, Gly and Arg) subsequently connected together [Fig. A.01]. The molecules have been tested in ex-vivo metabolism assay in liver, kidney and tumour tissues. Cytotoxicity has been tested for all compounds in M14 and DLD1 cell lines: no effect was observed in MTT assay. Migration inhibition has been evaluated by performing scratch assay on M14 and DLD1 cell lines. Compound 4 has shown the best migration inhibition, with IC50 = 4.62 ± 1.70 μM at 12h and IC50 = 5.63 ± 1.77 μM at 24h. [Fig A.01] The work made in this project can be used as preliminary evaluation for a deeper investigation in succinamides-based prodrugs as integrins antagonists.","abstract_has_math":false,"creators":["Dell’Albani, Arianna"],"institution":"University of Bradford","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Loadman, Paul","Shnyder, Steven","Sheldrake, Helen"],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-07-24T01:15:46Z","subjects":["Integrins","Succinamide","Synthesis","Alphavbeta3","Metabolism","isoDGR","RGD","Prodrug","Cyclization","Integrin antagonists"],"languages":["en"],"rights":["\"Creative
The University of Bradford theses are licenced under a Creative Commons Licence."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://bradscholars.brad.ac.uk/handle/10454/20643","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Loadman, Paul","Shnyder, Steven","Sheldrake, Helen"]},{"key":"dc:creator","label":"Author","values":["Dell’Albani, Arianna"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-10-28T14:42:36Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-10-28T14:42:36Z"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Pharmacy. Faculty of Life Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Bradford"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Integrins","Succinamide","Synthesis","Alphavbeta3","Metabolism","isoDGR","RGD","Prodrug","Cyclization","Integrin antagonists"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["\"Creative
The University of Bradford theses are licenced under a Creative Commons Licence."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://bradscholars.brad.ac.uk/handle/10454/20643"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Integrins are a family of cell surface protein receptors consisting of two subunits, called α and β, involved in several biological processes, including regulation of signalling between cells and other cells or ECM. Integrins are overexpressed in diseases, first of all cancer. Being able to bind several ligands which contain the endogenous peptidic motif, RGD, αvβ3 is the most important of the family, associated with angiogenesis and aggressiveness of the tumour. However, molecules designed as antagonists based on RGD have shown partial agonism. This limit may be overpassed by switching from RGD to isoDGR motif. Here, some isoDGR analogues prodrugs have been designed and synthesised, by a multi-step route to obtain the different fragments (isoAsp, Gly and Arg) subsequently connected together [Fig. A.01]. The molecules have been tested in ex-vivo metabolism assay in liver, kidney and tumour tissues. Cytotoxicity has been tested for all compounds in M14 and DLD1 cell lines: no effect was observed in MTT assay. Migration inhibition has been evaluated by performing scratch assay on M14 and DLD1 cell lines. Compound 4 has shown the best migration inhibition, with IC50 = 4.62 ± 1.70 μM at 12h and IC50 = 5.63 ± 1.77 μM at 24h. [Fig A.01] The work made in this project can be used as preliminary evaluation for a deeper investigation in succinamides-based prodrugs as integrins antagonists."]},{"key":"dc:title","label":"Title","values":["Evaluation of new succinimide-based small molecules as alphavbeta3 integrin antagonists: from design to preliminary biological testing"]}]}],"canonical_facts":{"dc:contributor.advisor":["Loadman, Paul","Shnyder, Steven","Sheldrake, Helen"],"dc:creator":["Dell’Albani, Arianna"],"dc:date.accessioned":["2025-10-28T14:42:36Z"],"dc:date.available":["2025-10-28T14:42:36Z"],"dc:description.abstract":["Integrins are a family of cell surface protein receptors consisting of two subunits, called α and β, involved in several biological processes, including regulation of signalling between cells and other cells or ECM. Integrins are overexpressed in diseases, first of all cancer. Being able to bind several ligands which contain the endogenous peptidic motif, RGD, αvβ3 is the most important of the family, associated with angiogenesis and aggressiveness of the tumour. However, molecules designed as antagonists based on RGD have shown partial agonism. This limit may be overpassed by switching from RGD to isoDGR motif. Here, some isoDGR analogues prodrugs have been designed and synthesised, by a multi-step route to obtain the different fragments (isoAsp, Gly and Arg) subsequently connected together [Fig. A.01]. The molecules have been tested in ex-vivo metabolism assay in liver, kidney and tumour tissues. Cytotoxicity has been tested for all compounds in M14 and DLD1 cell lines: no effect was observed in MTT assay. Migration inhibition has been evaluated by performing scratch assay on M14 and DLD1 cell lines. Compound 4 has shown the best migration inhibition, with IC50 = 4.62 ± 1.70 μM at 12h and IC50 = 5.63 ± 1.77 μM at 24h. [Fig A.01] The work made in this project can be used as preliminary evaluation for a deeper investigation in succinamides-based prodrugs as integrins antagonists."],"dc:identifier.uri":["https://bradscholars.brad.ac.uk/handle/10454/20643"],"dc:language.iso":["en"],"dc:publisher.department":["School of Pharmacy. Faculty of Life Sciences"],"dc:publisher.institution":["University of Bradford"],"dc:rights":["\"Creative
The University of Bradford theses are licenced under a Creative Commons Licence."],"dc:subject":["Integrins","Succinamide","Synthesis","Alphavbeta3","Metabolism","isoDGR","RGD","Prodrug","Cyclization","Integrin antagonists"],"dc:title":["Evaluation of new succinimide-based small molecules as alphavbeta3 integrin antagonists: from design to preliminary biological testing"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["PhD"]},"updated_at":"2026-07-24T01:15:46Z"}